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ABSTRACT
Objective: In view of marked accentuations in cardiometabolic diseases in developing countries such as India, we aimed to conduct a cross-sectional 
study analyzing the prevalence of cardiometabolic risk factors in local population of Ghaziabad.
Methods: The study is descriptive, random sample survey, and cross-sectional study. The study was carried out at Santosh Medical College, Ghaziabad, 
on 350 participants between the age group 18-70 years. After taking the informed consent, they were included in the study. The variables recorded 
were clinical history, all risk factors of cardiovascular disease including blood pressure, body mass index, waist circumference, blood sugar and serum 
lipid levels, cigarette use, and dietary habit.
Result: Our study shows that the high prevalence of multiple risk factors in a general population with as many as 70% of the participants had 
metabolic syndrome. Among individually studied groups, obesity was the most common followed by dyslipidemia then diabetes and hypertension and 
the least prevalent was smoking. Females were more commonly affected than males by dyslipidemia and obesity, probably due to physical inactivity 
coupled with unhealthy diet and lifestyle.
Conclusion: There is the higher prevalence of cardiometabolic risk factors among the population making the individuals prone to associated 
spontaneous coronary artery dissection and their predisposition. Therefore, timely detection of cardiometabolic factors and appropriate interventions 
may be of prime concern.
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INTRODUCTION
One of the major causes of mortality and morbidity, the cardiometabolic 
diseases are emerging as an important health concern in developing 
and developed countries. Predominantly, they are lifestyle-related 
diseases having various modifiable and non-modifiable risk factors. 
Smoking, sedentary lifestyle, psychosocial stress, and obesity are 
modifiable risk factors while diabetes mellitus, hypercholesterolemia, 
and hypertension metabolic syndrome are non-modifiable risk 
factors [1]. These factors if not timely checked or controlled may 
lead to ischemic heart disease secondary to atherosclerotic coronary 
vascular disease [1-3]. Besides all these parameters, homocysteine 
level, elevated coronary artery calcium, marked carotid intima-media 
thickness, aortic pulse wave velocity as a measure of arterial stiffness, 
elevated C-reactive protein, elevated lipoproteins(a), fibrinogen, 
plasminogen activator inhibitor, platelet count, lipoprotein-associated 
phospholipase A2 are few other non-conventional markers but their 
clinical relevance has not been established [4]. There are substantial 
variations present at country, regional, and urban-rural levels due 
to lifestyle variations such as dietary factors, physical activity, and 
smoking. In India, also a number of studies conducted and have shown 
the prevalence of obesity, hypertension, hypercholesterolemia, and 
diabetes in urban as compared to rural population [5,6]. Various ethnic 
and sociocultural differences are responsible for this vast geographical 
variation in cardiometabolic risk factors. Due to marked accentuation 
in cardiometabolic diseases in developing countries such as India, it is 
necessary to study the various cardiometabolic risk factors in a local 
population such as Ghaziabad as there is no population-based cross-
sectional study analyzing the prevalence of cardiometabolic risk factors 
in this part of the world.
METHODS
It was a hospital-based cross-sectional study carried out at Santosh 
Medical College and Hospital, Ghaziabad during the past 2 years from 
2015 to 2016. Total 350 participants between the age group 18 and 
70 years were included in the study after receiving their written consent. 
Following are the inclusion criteria for selection of participants:
Waist circumference - >90 cm for males and >80 cm for females. 
Dyslipidemia - Triglycerides >150 mg/dl and are on no specific 
medication. High-density lipoprotein cholesterol (HDLc): <40 and 
50 mg/dl, respectively, for males and females with no medication. 
Hypertension: Blood pressure (BP) ≥130 mm Hg and systolic BP ≥85 
with no specific medication. Fasting plasma glucose (FPG) ≥100 mg/dl, 
post-prandial plasma glucose 140-199 mg/dl or hemoglobin A1c - 5.7-
6.4%. All diabetic patients were irrespective of specific treatment 
for diabetes. All patients who were diagnosed as having metabolic 
syndrome as per Asian Specific Harmonized Criteria.
Patients suffering from coronary artery disease and atherosclerotic 
coronary vascular diseases, chronic granulomatous diseases such 
as tuberculosis and leprosy or any oncological diseases, hepatic 
impairment and thyroid disorder were excluded from the study.
The participants were evaluated and selected by detailed medical 
history, physical examination, systemic examination, or routine 
investigations to rule out any underlying disease.
All patients were subjected to measurement of height, weight, body 
mass index (BMI), and waist circumference and waist-hip ratio [6]. FPG 
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estimation was done by glucose oxidase and peroxidase, i.e., glucose 
oxidase-peroxidase method [7]. Electrocardiogram was done to rule 
out coronary artery disease/atherosclerotic coronary vascular disease. 
Total serum cholesterol estimation was done using cholesterol oxidase-
phenol 4-aminophenazone peroxidase method [8]. Triglycerides (TGs) 
estimation was done by GPO-Trinder method [8]. Very low-density 
lipoprotein cholesterol (LDLc) and LDLc concentration estimation 
were done using Friedwald’s formula. HDLc estimation was done 
by polyethylene glycerol methyl ether coupled classic precipitation 
method [8]. All data were analyzed and reported as mean with 
standard using group and descriptive statistics using SPSS database. 
Independent Student’s t-test was done to find out the significance 
(p value) between data of male and female test group. p<0.05 was 
considered as statistically significant.
RESULTS
The participants consisted of 171 males and 179 females with the 
prevalence of 48.86% and 51.14%, respectively. Largest number of 
participants of studied population belongs to the age group 40-49 years 
of age. The prevalence of various cardiometabolic risk factors in 
the study group was represented by metabolic syndrome which is 
affecting 245 (70%) out of participants and is the most important 
risk factor. Next, the most common factor was obesity with 56.9% 
prevalence including 199 out of 350 people, followed by dyslipidemia, 
diabetes, and hypertension with 51.1%, 45.1%, and 44.9% prevalence, 
respectively. The least prevailing factor was smoking with 4.3% 
(Table 1).
Table 2 illustrates the various risk factors as variables studied among 
350 participants. The analyzed variables were studied in both men 
and women. The most commonly encountered risk factor among study 
participants was raised total cholesterol at 247.8±57.89 in women and 
247.3±58.82 among men. The difference between the two groups is not 
statistically significant (0.957). Among other variables, the difference in 
prevalence of obesity (BMI >30 kg/m2) and smoking were statistically 
significant at p=0.023 and 0.003, respectively.
Table 3 is showing the prevalence of various risk factors with obesity. 
It is seen that the prevalence of raised cholesterol at 234.68±33.51 in 
obese participants and 274.27±84.10 in non-obese participants was the 
most commonly seen risk factor. The difference between the two groups 
was statistically significant (p=0.000). The difference in prevalence of 
central abdominal obesity with waist circumference >90 cm (0.000) in 
men and >80 cm in women along with metabolic syndrome was also 
significant (0.000).
DISCUSSION
It was planned to study the prevalence of major modifiable and 
non-modifiable factors in the general population, attending 
hospital outpatient department in Ghaziabad. The study included 
350 participants of 18-70 years of age; the largest group was 
represented by 40-49 years. An important focus of recent studies is 
the changing trends in cardiovascular risk factors. In the past 30 years, 
the prevalence of hypertension and hypercholesterolemia has doubled 
while that of diabetes has tripled. In our study, we found metabolic 
syndrome as the most prevalent risk factor affecting 245 (70%) study 
participants out 350 while smoking was the least prevalent risk factor 
including just 15 (4.3%) people from our study population. We found 
the prevalence of hypertension, dyslipidemia, and diabetes to be 44.9%, 
51.1%, and 45.1%, respectively (Table 1). The results obtained are 
having higher values than Jaipur Heart Watch-6 study which reported 
the prevalence of hypertension, dyslipidemia (TG ≥200 mg/dl) and 
diabetes to be 36%, 25.8%, and 19.2%, respectively. The Jaipur Heart 
Watch studies in India evaluated multiple cardiovascular risk factors 
in urban middle-class participants using multiple cross-sectional study 
design over a 20 year period from 1991 to 2010 [9]. During the period, 
the prevalence of smoking declined, no chance in hypertension was 
observed while all other risk factors such as obesity, truncal obesity, 
hypercholesterolemia, diabetes, and metabolic syndrome increased 
significantly. The data was analyzed by plotting graph of individual 
risk factors among male and female groups. More number of females 
was found to be associated with raised total cholesterol as compared 
to males. Data on hypercholesterolemia in our study reveal consistency 
with India Migratory Study including 1983 participants [10]. Obesity 
in our study was considered as patients having BMI ≥30 kg/m2 was 
35.04±4.02 (Table 2). When the difference in the mean and standard 
deviation (SD) assessed in between male and female group, it was 
found statically significant (0.023). On plotting difference in mean 
and SD, between male and female group across other parameters of 
obesity, namely, BMI ≥25 kg/m2 but <30 kg/m2 and waist to hip ratio 
(men >0.9; women >0.8 cm), it was found that female group had higher 
values than male group for the risk factor considered. The difference 
in their prevalence was however not statistically significant (p>0.05). 
All other risk factors of importance and their respective prevalence 
in obese participants (n=191) were studied and compared with non-
obese study participants (n=151). It was seen that the prevalence of 
Table 1: The prevalence of various cardiometabolic risk factors 
in the study group of 350 patients





Metabolic syndrome 245 (70)
Smoking 15 (4.3)
Table 2: Comparative analysis of various cardiometabolic risk factors in men and women
Variables Mean±SD p value
Total (n=350) Women (n=179) Men (n=171)
Obesity BMI ≥25 kg/m2 and <30 kg/m2 27.18±1.33 27.22±1.23 27.14±1.42 0.701
BMI ≥30 kg/m2 35.04±4.02 35.63±4.17 34.32±3.72 0.023
W:H ratio (men >0.9; women >0.8 cm) 0.99±0.53 1±0.05 0.99±0.05 0.337
Diabetes (FBS≥100 mg/dl) 164±72.02 161.1±72 167.4±72.3 0.538
HTN (known hypertensive; systolic BP ≥130 mmHg, and diastolic 
BP ≥85 mmHg)
147.2±80.12 148.1±19.5 146.2±16.6 0.458
Dyslipidemia (Total cholesterol ≥200 mg/dl) 247.6±58.11 247.8±57.9 247.3±58.8 0.957
TGL ≥150 mg/dl 224.4±87.94 221.5±77.3 227.5±98.5 0.656
LDL ≥130 mg/dl 168.6±33.44 171.2±36.8 165.3±28.6 0.318
HDL <40 mg/dl for male; <50 for female 47.15±10.12 39.01±5.92 34.33±4.41 0.631
Metabolic syndrome 1.3±0.459 1.26±0.44 1.34±0.48 0.119
Smokers 1.96±0.2 1.99±0.11 1.92±0.27 0.003
HTN: Hypertension, HDL: High-density lipoprotein, LDL: Low-density lipoprotein, BP: Blood pressure, FBS: Fasting blood sugar, SD: Standard deviation, BMI: Body mass 
index
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raised total cholesterol at 234.68±33.51 in obese participants and 
274.27±84.10 in non-obese participants (Table 3) was most commonly 
seen risk factor. The difference in mean between the two groups was 
statistically significant (p=0.000). The difference in means of prevalence 
of central abdominal obesity with waist circumference >90 cm (0.000) 
in men and >80 cm in women along with metabolic syndrome was also 
statistically significant (0.000) (Table 3). Similar results were reported 
by DS Prasad et al. [10]. Numerous other epidemiological studies also 
show that BMI is a powerful predictor of Type 2 diabetes, hypertension, 
hypercholesterolemia, and heart diseases [11-15].
CONCLUSION
The study shows the higher prevalence of multiple risk factors in a 
general population with as many as 70% (n=245) participants were 
having metabolic syndrome. Among the groups, obesity was the most 
common followed by dyslipidemia then diabetes, hypertension, and 
least prevalent factor was smoking. Females were most commonly 
affected than males by dyslipidemia and obesity, probably due to 
physical inactivity coupled with unhealthy lifestyle. Therefore, Indians 
are at high risk for ASCVD and their predisposition. Early identification 
of cardiometabolic risk factors and appropriate intervention may be of 
primary importance in population.
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